| Bioactivity | IRGRILHDGAYSLTLQGLGIH is a multi-epitope class II rat HER2/neu peptide. IRGRILHDGAYSLTLQGLGIH can be used for the research class II HER2-DC1 vaccine studies[1]. |
| Name | IRGRILHDGAYSLTLQGLGIH |
| CAS | 1443436-79-0 |
| Sequence | Ile-Arg-Gly-Arg-Ile-Leu-His-Asp-Gly-Ala-Tyr-Ser-Leu-Thr-Leu-Gln-Gly-Leu-Gly-Ile-His |
| Shortening | IRGRILHDGAYSLTLQGLGIH |
| Formula | C102H168N32O28 |
| Molar Mass | 2290.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kodumudi KN, et, al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019 Aug 14;10:1939. |
IRGRILHDGAYSLTLQGLGIH
CAS: 1443436-79-0 F: C102H168N32O28 W: 2290.62
IRGRILHDGAYSLTLQGLGIH is a multi-epitope class II rat HER2/neu peptide. IRGRILHDGAYSLTLQGLGIH can be used for the resear
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.